ID

26884

Beskrivning

A Study to Compare Subcutaneous Versus Intravenous Administration of Herceptin (Trastuzumab) in Women With HER2-Positive Early Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00950300

Länk

https://clinicaltrials.gov/show/NCT00950300

Nyckelord

Versioner (1)
  1. 2017-10-27 2017-10-27 -
Rättsinnehavare

See clinicaltrials.gov

Uppladdad den

27 oktober 2017

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Breast Cancer NCT00950300

Engelsk

Eligibility Breast Cancer NCT00950300

1 Formulär  
Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
adult women >/= 18 years of age
Beskrivning

Adult | Gender | Age

Datatyp

boolean

Alias
UMLS CUI [1]
C0001675
UMLS CUI [2]
C0079399
UMLS CUI [3]
C0001779
non-metastatic primary invasive adenocarcinoma of the breast clinical stage i-iiic, including inflammatory and multicentric breast cancer, tumour size >/= 1 cm, histologically confirmed, her2-positive
Beskrivning

Breast adenocarcinoma Invasive Primary TNM Breast tumor staging | Inflammatory Breast Carcinoma | Multicentric Breast Carcinoma | Tumor size | HER2-positive carcinoma of breast

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0858252
UMLS CUI [1,2]
C0205281
UMLS CUI [1,3]
C0205225
UMLS CUI [1,4]
C0474926
UMLS CUI [2]
C0278601
UMLS CUI [3]
C2986664
UMLS CUI [4]
C0475440
UMLS CUI [5]
C1960398
at least 1 measurable lesion in breast or lymph nodes according to recist v1.0 criteria, except for inflammatory carcinoma
Beskrivning

Measurable lesion Quantity Breast | Measurable lesion Quantity Lymph nodes | Exception Inflammatory carcinoma

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0006141
UMLS CUI [2,1]
C1513041
UMLS CUI [2,2]
C1265611
UMLS CUI [2,3]
C0024204
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0334385
baseline lvef >/= 55%
Beskrivning

Left ventricular ejection fraction

Datatyp

boolean

Alias
UMLS CUI [1]
C0428772
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
history of any prior (ipsi- and/or contralateral) invasive breast carcinoma
Beskrivning

Invasive carcinoma of breast Ipsilateral | Invasive carcinoma of breast Contralateral

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0853879
UMLS CUI [1,2]
C0441989
UMLS CUI [2,1]
C0853879
UMLS CUI [2,2]
C0441988
past or current history of malignant neoplasms, except for curatively treated basal and squamous cell carcinoma of the skin and in situ carcinoma of the cervix
Beskrivning

Malignant Neoplasms | Exception Curative treatment Basal cell carcinoma | Exception Curative treatment Squamous cell carcinoma of skin | Exception Curative treatment Carcinoma in situ of uterine cervix

Datatyp

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C1273390
UMLS CUI [2,3]
C0007117
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C1273390
UMLS CUI [3,3]
C0553723
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C1273390
UMLS CUI [4,3]
C0851140
metastatic disease
Beskrivning

Neoplasm Metastasis

Datatyp

boolean

Alias
UMLS CUI [1]
C0027627
any prior therapy with anthracyclines
Beskrivning

Anthracyclines

Datatyp

boolean

Alias
UMLS CUI [1]
C0282564
prior anti-her2 therapy or biologic or immunotherapy
Beskrivning

Therapeutic procedure HER2 Targeted | Biological treatment | Immunotherapy

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0242957
UMLS CUI [1,3]
C1521840
UMLS CUI [2]
C1531518
UMLS CUI [3]
C0021083
serious cardiac illness
Beskrivning

Heart Disease Serious

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0018799
UMLS CUI [1,2]
C0205404
pregnant or lactating women
Beskrivning

Pregnancy | Breast Feeding

Datatyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
Tillbaka till toppen

Similar models

Eligibility Breast Cancer NCT00950300

1 Formulär
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
Adult | Gender | Age
Item
adult women >/= 18 years of age
boolean
C0001675 (UMLS CUI [1])
C0079399 (UMLS CUI [2])
C0001779 (UMLS CUI [3])
Breast adenocarcinoma Invasive Primary TNM Breast tumor staging | Inflammatory Breast Carcinoma | Multicentric Breast Carcinoma | Tumor size | HER2-positive carcinoma of breast
Item
non-metastatic primary invasive adenocarcinoma of the breast clinical stage i-iiic, including inflammatory and multicentric breast cancer, tumour size >/= 1 cm, histologically confirmed, her2-positive
boolean
C0858252 (UMLS CUI [1,1])
C0205281 (UMLS CUI [1,2])
C0205225 (UMLS CUI [1,3])
C0474926 (UMLS CUI [1,4])
C0278601 (UMLS CUI [2])
C2986664 (UMLS CUI [3])
C0475440 (UMLS CUI [4])
C1960398 (UMLS CUI [5])
Measurable lesion Quantity Breast | Measurable lesion Quantity Lymph nodes | Exception Inflammatory carcinoma
Item
at least 1 measurable lesion in breast or lymph nodes according to recist v1.0 criteria, except for inflammatory carcinoma
boolean
C1513041 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0006141 (UMLS CUI [1,3])
C1513041 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0024204 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C0334385 (UMLS CUI [3,2])
Left ventricular ejection fraction
Item
baseline lvef >/= 55%
boolean
C0428772 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Invasive carcinoma of breast Ipsilateral | Invasive carcinoma of breast Contralateral
Item
history of any prior (ipsi- and/or contralateral) invasive breast carcinoma
boolean
C0853879 (UMLS CUI [1,1])
C0441989 (UMLS CUI [1,2])
C0853879 (UMLS CUI [2,1])
C0441988 (UMLS CUI [2,2])
Malignant Neoplasms | Exception Curative treatment Basal cell carcinoma | Exception Curative treatment Squamous cell carcinoma of skin | Exception Curative treatment Carcinoma in situ of uterine cervix
Item
past or current history of malignant neoplasms, except for curatively treated basal and squamous cell carcinoma of the skin and in situ carcinoma of the cervix
boolean
C0006826 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C1273390 (UMLS CUI [2,2])
C0007117 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C1273390 (UMLS CUI [3,2])
C0553723 (UMLS CUI [3,3])
C1705847 (UMLS CUI [4,1])
C1273390 (UMLS CUI [4,2])
C0851140 (UMLS CUI [4,3])
Neoplasm Metastasis
Item
metastatic disease
boolean
C0027627 (UMLS CUI [1])
Anthracyclines
Item
any prior therapy with anthracyclines
boolean
C0282564 (UMLS CUI [1])
Therapeutic procedure HER2 Targeted | Biological treatment | Immunotherapy
Item
prior anti-her2 therapy or biologic or immunotherapy
boolean
C0087111 (UMLS CUI [1,1])
C0242957 (UMLS CUI [1,2])
C1521840 (UMLS CUI [1,3])
C1531518 (UMLS CUI [2])
C0021083 (UMLS CUI [3])
Heart Disease Serious
Item
serious cardiac illness
boolean
C0018799 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
Pregnancy | Breast Feeding
Item
pregnant or lactating women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial